Baycrest Centre For Geriatric Care
Toronto, ON Doing business as Baycrest Hospital Research Division
- UEI
- G96HF8PJ3LE6
- CAGE
- L5778
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- International Organization
- SAM.gov registration date
- Physical address
- 3560 Bathurst St, North York, ON M6A 1W1, Canada
- Website
- baycrest.org
- Founded
- 1918
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Trustees Of The University Of Pennsylvania | R01AG075111 | $241,630 | |
| The Trustees Of The University Of Pennsylvania | R01AG075111 | $295,738 | |
| Wayne State University | R01AG070592 | $55,460 | |
| The Trustees Of The University Of Pennsylvania | R01AG075111 | $295,738 | |
| Wayne State University | R01AG070592 | $190,120 |
Similar vendors
About the company
Baycrest Centre For Geriatric Care Research Division, doing business as Baycrest Hospital, is a Canadian non-profit research organization based in Toronto that participates in NIH-funded clinical research as a sub-recipient on federal grants focused on neurodegenerative disease and cognitive aging. The organization has not held federal contract prime awards but operates as a sub-recipient on five federal grant sub-awards, accounting for 62% of its recent federal footprint, with the balance split between three prime grant awards.
Baycrest's federal work centers on dementia research and clinical trial execution, specifically leading the Canadian component of NIH Phase II transcranial direct current stimulation (tDCS) clinical trials for Primary Progressive Aphasia conducted under the direction of Dr. Howard Chertkow, the Scientific Director of the Canadian Consortium on Neurodegeneration in Aging. In this capacity, Baycrest recruits and screens participants at Toronto and Montreal-based laboratories, administers tDCS interventions under blinded protocols, coordinates MRI imaging, conducts bilingual-specific cognitive and language assessments, manages participant data, and contributes to research dissemination. Recent sub-award work includes a February 2026 award from the University of Pennsylvania (as prime grantee) for the Canadian arm of the Phase II tDCS-PPA trial, a December 2025 award from the University of Pennsylvania for Dr. Chertkow's research coordination and patient recruitment efforts (1.8 person-months, 15% effort), and October 2025 and February 2023 awards from Wayne State University for dissemination of a harmonized brain-imaging segmentation protocol and statistical support on related aims.
Federal funding concentration is complete — 100% of awards derive from the Department of Health and Human Services National Institutes of Health, split between the National Institute on Aging (5 awards) and general NIH programs (3 awards). Combined dollars obligated across all eight awards total $3.2 million. Activity has remained sparse but recent — one award in each of 2023 and 2024, two in 2025, and one in 2026. No federal contracts or parent vehicles are present in the footprint.
Quick answers
Is Baycrest Centre For Geriatric Care registered in SAM.gov?
Yes. Baycrest Centre For Geriatric Care's SAM.gov registration is active through December 1, 2026.
What is Baycrest Centre For Geriatric Care's most recent federal award?
Baycrest Centre For Geriatric Care's most recent federal grant award is Relation of beta-amyloid deposition to temporal lobe-focused dementias (R03AG034413), from National Institutes of Health, on September 1, 2011.
On GovTribe
See Baycrest Centre For Geriatric Care's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors